Bibliography
- EMA . ICH M3 (R2) Guideline: Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. EMA, London, UK (2009).
- Diehl KH , HullR, MortonDet al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 21, 15–23 (2001)
- European Parliament and of the Council of the EU. Directive 2010/63/EU on the protection of animals used for scientific purposes. Official J. EU276, 33–79 (2010).
- Russell WMS , BurchRL. The Principles of Humane Experimental Technique. London, UK,238 (1959).
- Abbott RW . The broadening scope of validation: towards best practices in the world of bioanalysis. Bioanalysis2(4), 703–708 (2010).
- Spooner N . A glowing future for dried blood spot sampling. Bioanalysis2(8), 1343–1344 (2010).
- Abbott R , SmeragliaJ, WhiteSet al. Connecting strategies on dried blood spots. Bioanalysis2(11), 1809–1816 (2010).
- Hill H . Developing trends in bioanalysis. Bioanalysis1(8), 1359–1364 (2009).
- Evans CA , BruceC, EmmonsGTet al. Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation and best practices. Bioanalysis2(8), 1355–1359 (2010).
- Denniff P , SpoonerN. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis2(8), 1385–1395 (2010).